comparemela.com
Home
Live Updates
Functional Improvement Seen With C1q Inhibitor in Guillain-Barré Syndrome : comparemela.com
Functional Improvement Seen With C1q Inhibitor in Guillain-Barré Syndrome
ANX005 is a C1q inhibitor that is administered intravenously and works by blocking the activation of classical complement pathway.
Related Keywords
Bangladesh ,
Philippines ,
,
International Guillain Barr ,
Drug Administration ,
Research Council ,
Peripheral Nerve Society Annual Meeting On ,
Medical Research Council ,
Douglas Love ,
Western International Guillain Barr ,
Syndrome Outcomes Study ,
Biologics License Application ,
Nerve Society Annual Meeting ,
Fast Track ,
Orphan Drug ,
comparemela.com © 2020. All Rights Reserved.